Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology | Family Medicine

Dermatitis, Atopic Clinical Trials


A listing of Dermatitis, Atopic medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Mobile :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Arizona

Hot Springs :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

California

Cypress : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Encino :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Glendale : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Oceanside :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

San Diego :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Colorado

Denver :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Denver : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Florida

Jacksonville :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Miami :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Miami : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Miramar :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Orange Park :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

View More »

Pinellas Park :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Tampa :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Tampa :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Idaho

Boise :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Illinois

Arlington Heights :

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Chicago : Northwestern University, Department of Dermatology

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

Indiana

Carmel :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Michigan

Fort Gratiot :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Minnesota

Fridley :

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

New Jersey

Berlin :

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Verona :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

New York

New York : Call for Information (Investigational Site 0002) Updated

A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)

Stony Brook :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

North Carolina

High Point :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Salem :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Winston-Salem : Wake Forest University Health Sciences

Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis

Ohio

South Euclid :

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Sylvania :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Oregon

Lake Oswego :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Portland :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Portland :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Portland : Oregon Health & Science University Center for Health & Healing

Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants

Portland : Oregon Health & Science University, Department of Dermatology

Eczema Prevention Study

View More »

Portland :

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Portland : Oregon Health & Science University Department of Dermatology

VANOS Cream and Skin Barrier Function

Pennsylvania

Philadelphia : Registry

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Pittsburgh : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Rhode Island

Johnston :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Texas

Austin :

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

College Station :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

College Station :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Dallas :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Houston : University of Texas Medical School - Houston

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

View More »

San Antonio :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

San Antonio :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Webster :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Utah

Draper :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Virginia

Henrico :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Norfolk :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Washington

Spokane :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Wisconsin

Madison : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Austria

Vienna : Novartis Investigative Site

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Canada

Kirkland : Merck Frosst Canada Ltd. Updated

A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)

China

Beijing :

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Chongqing :

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Guangzhou :

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Shanghai :

Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

Czech Republic

Nachod :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Svitavy :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Usti nad Labem :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Estonia

Tallinn :

Emollients in the Management of Atopic Dermatitis

Tartu :

Emollients in the Management of Atopic Dermatitis

Finland

Helsinki :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Tampere :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Germany

Berlin : Universitätsmedizin Charité Berlin, Abteilung für Dermatologie und Allergologie

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Berlin :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Berlin :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Bonn :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Dresden :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

View More »

Erfurt :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Frankfurt :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Frankfurt :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Gera :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Hannover :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Heidelberg :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Kiel :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Mahlow :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Mainz :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Münster : Universitätsklinikum Münster, Klinik für Hautkrankheiten

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Münster :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Osnabrueck :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Tuebingen :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Hungary

Kaposvar :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Szeged :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Szekszard :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Szolnok :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Lithuania

Vilnius :

Emollients in the Management of Atopic Dermatitis

Poland

Bydgoszcz :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Gdansk :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Lodz :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Lublin :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Poznan :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

View More »

Warszawa :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Warszawa :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Witosa :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Wroclaw :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Sweden

Stockholm : Sophiahemmet

Effect of Moisturizing Creams on Skin Barrier Function

Taiwan

United Kingdom

Manchester : Local Institution

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis